Investment Funds Buy Gilead Shares as Quarterly Dividend Is Announced
Roberts Glore & Co. IL bought 9,885 shares of Gilead Sciences for about $1.25 million, while Vermillion & White Wealth Management Group increased its stake. Analysts adjusted price targets and reiterated buy or sector-perform ratings. Gilead also announced a quarterly dividend of $0.82 per share, payable Sept. 29 to holders on Sept. 15.